Found 0 matching trials
A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment PHASE3 This study is researching a clinical treatment combination with two experim...
Show More Status
Active Not Recruiting
Location
The Oncology Institute of Hope & Innovation
Learn More & Join Trial
Real-life Treatment Outcomes of Ravulizumab in PNH N/A The PNH-RECORD study, a Polish multicenter observational (non-interventiona...
Show More Status
Active Not Recruiting
Learn More & Join Trial
ALXN1210 (Ravulizumab) Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) PHASE3 The primary purpose of this study was to assess the noninferiority of ravul...
Show More Learn More & Join Trial
Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis N/A The primary objective of the study is to evaluate the effectiveness of Ravu...
Show More Location
Clinical Trial Site
Learn More & Join Trial
Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis PHASE3 The primary purpose of this study is to characterize the pharmacokinetics a...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Open-label, Multiple Ascending Dose Study of Ravulizumab (ALXN1210) in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) PHASE2 The primary purpose of this study is to evaluate the safety, tolerability, ...
Show More Location
Clinical Trial Site
Learn More & Join Trial
Efficacy and Safety of Ravulizumab in Chinese Adults Participants With Generalized Myasthenia Gravis (gMG) PHASE3 The primary purpose of this study is to evaluate the efficacy, safety, phar...
Show More Learn More & Join Trial
A Study of a Single Subcutaneous Dose of ALXN1210 in Healthy Adult Participants PHASE1 This study evaluated the safety and tolerability of a single dose of ALXN12...
Show More Location
Clinical Trial Site
Learn More & Join Trial
Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD PHASE2 The primary purpose of this study is to evaluate the safety and efficacy of...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Real Life Use of Ravulizumab in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria N/A This study will collect clinical response data on participants who were alr...
Show More Location
Clinical Trial Site
Learn More & Join Trial